Clinical trial
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
NCT00179803 · Ann & Robert H Lurie Children's Hospital of Chicago, Other · Completed
Key facts
| NCT number | NCT00179803 |
|---|---|
| Title | Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors |
| Official title | Phase II Prospective Study of Sequential Myeloablative Chemotherapy With Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors |
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma, Astrocytoma, Pineoblastoma, Rhabdoid Tumor, Supratentorial Neoplasms |
| Intervention type | Procedure |
| Interventions | Stem Cell Transplant |
| Enrollment | 24 |
| Start date | Mar 1, 1998 |
| Primary completion | Jan 1, 2008 |
| Completion | Sep 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 5, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: